Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth

NCT ID: NCT05024084

Last Updated: 2021-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-05

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Minimal flow anesthesia has economic and environmental advantages in addition to providing earlier recovery following general anesthesia. There is a paucity of data concerning the effect of minimal flow anesthesia (fresh gas flow \<0,5 l/min) on recovery parameters. The primary objective of this study is to compare the recovery parameters of desflurane and sevoflurane in minimal flow anesthesia while the secondary objective is to compare the effect of these agents on anesthetic depth using bispectral index.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group Sevoflurane

The patients in this arm will be given Sevoflurane (2-3%) as volatile anesthetic throughout the duration of anesthesia.

Group Type ACTIVE_COMPARATOR

Minimal flow anesthesia (fresh gas flow <0.5 l/min) using Sevoflurane

Intervention Type PROCEDURE

Sevoflurane will be used for the maintenance of general anesthesia which will be carried out using a fresh gas flow of less than 0,5 l/min

Group Desflurane

The patients in this arm will be given Desflurane (7-8%) as volatile anesthetic throughout the duration of anesthesia.

Group Type ACTIVE_COMPARATOR

Minimal flow anesthesia (fresh gas flow <0.5 l/min) using Desflurane

Intervention Type PROCEDURE

Desflurane will be used for the maintenance of general anesthesia which will be carried out using a fresh gas flow of less than 0,5 l/min

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minimal flow anesthesia (fresh gas flow <0.5 l/min) using Sevoflurane

Sevoflurane will be used for the maintenance of general anesthesia which will be carried out using a fresh gas flow of less than 0,5 l/min

Intervention Type PROCEDURE

Minimal flow anesthesia (fresh gas flow <0.5 l/min) using Desflurane

Desflurane will be used for the maintenance of general anesthesia which will be carried out using a fresh gas flow of less than 0,5 l/min

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages between 18 and 65
* Patients undergoing elective surgery under general anesthesia
* Patients with an American Society of Anesthesiologists Classification I or II

Exclusion Criteria

* Patient refusal
* Emergency surgery
* Patients with a contraindication for minimal flow anesthesia
* Uncontrolled diabetes mellitus
* History of serious systemic disease (cardiac, pulmonary, hepatic)
* Utilization of another analgesic technique such as central or peripheral nerve blocks
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ufuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Baturay Kansu Kazbek

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Baturay K Kazbek, Ass. Prof.

Role: PRINCIPAL_INVESTIGATOR

Ufuk University Faculty of Medicine Department of Anesthesiology and Reanimation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ufuk University Dr. Rıdvan Ege Hospital

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Baturay K Kazbek, Ass. Prof.

Role: CONTACT

+903122044000 ext. 4099

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Baturay K Kazbek, Ass. Prof.

Role: primary

+903122044000 ext. 4099

References

Explore related publications, articles, or registry entries linked to this study.

Taskin D, Gedik E, Kayhan Z. Effects of Minimal Flow Sevoflurane or Desflurane Anaesthesia on Hemodynamic Parameters, Body Temperature and Anaesthetic Consumption. Turk J Anaesthesiol Reanim. 2020 Oct;48(5):356-363. doi: 10.5152/TJAR.2020.39699. Epub 2020 May 5.

Reference Type BACKGROUND
PMID: 33103139 (View on PubMed)

Werner JG, Castellon-Larios K, Thongrong C, Knudsen BE, Lowery DS, Antor MA, Bergese SD. Desflurane Allows for a Faster Emergence When Compared to Sevoflurane without Affecting the Baseline Cognitive Recovery Time. Front Med (Lausanne). 2015 Oct 28;2:75. doi: 10.3389/fmed.2015.00075. eCollection 2015.

Reference Type BACKGROUND
PMID: 26579522 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sevoflurane in Electroconvulsive Therapy
NCT01905904 COMPLETED PHASE4